Recent studies have pointed out that SIRT3 is a critical regulator of cell metabolism and played a dual role in cancer, as it can act as a suppressor or promoter in a variety of tumors [69], such as breast cancer, colon cancer, and prostate cancer [70–76]. This evidence concerns the gene SIRT3 and prostate carcinoma.